InvestorsHub Logo
Followers 7
Posts 1333
Boards Moderated 0
Alias Born 04/16/2009

Re: None

Friday, 05/23/2014 8:48:12 PM

Friday, May 23, 2014 8:48:12 PM

Post# of 58861
PHASE III
Develop a plan to establish in-house detectability methods for electronic components that are 100% accurate in detecting remarked product. Determine implementation timeframe, and develop a cost estimate and time estimate for using equipment available for purchase to be used within the purchasing facility to determine whether components have been recoated. This in-house assessment capability must be stand-alone, but may include exchange of data with the developer in order to confirm encoded DNA information is accurate. MDA and developer present final information to DoD to develop plan forward for adoption (e.g., no adoption, adoption for only critical semiconductor components, full adoption). COMMERCIALIZATION: The developer will pursue commercialization of the various technologies and processes developed in prior Phases potential commercial uses in electronic components, and assess potential for marking mechanical parts or materials, labels, and other items determined to be at high risk for counterfeiting.


http://sbirsource.com/grantiq#/topics/86893
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APDN News